KD014
KD014 (DX-2400) is a human monoclonal antibody (mAb) targeting MMP14 (Ki: 0.9 nM) . KD014 inhibits TGFβ and SMAD2/3 activity, increases macrophage numbers and iNOS expression, and shifts macrophage phenotype toward anti-tumor M1-like. KD014 has anti-tumor activity in three different tumor models (MDA-MB-231, MDA-MB-435, and PC3) . KD014 can be used in breast cancer research[1][2].
Product Specifications
Product Name Alternative
DX-2400; DX-2410
UNSPSC
12352203
Target
MMP; NO Synthase; TGF-beta/Smad; TGF-β Receptor
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; Stem Cell/Wnt; TGF-beta/Smad
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Purity
96.98
Molecular Weight
(144.01 kDa)
References & Citations
[1]Ager EI, et al. Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy. J Natl Cancer Inst. 2015 Feb 20;107 (4) :djv017.|[2]Devy L, et al. Antitumor efficacy of DX-2400, a potent and selective human antibody MMP-14 inhibitor discovered using phage display technology[J]. Cancer Research, 2007, 67 (9_Supplement) : 5618-5618.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Isoform
MMP-14
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9331397-01 48 Well
Human TATA box-binding protein-associated factor RNA polymerase I subunit B, TAF1B ELISA Kit
Sign In for Pricing
View Details MBS9331397-02 96 Well
Human TATA box-binding protein-associated factor RNA polymerase I subunit B, TAF1B ELISA Kit
Sign In for Pricing
View Details